Longeveron Inc (LGVN)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | Mr. Paul T. LehrGeneral Counsel & Secretary | -5.61k | 6.28k | Sale to Issuer | 1.12 | 338.57k | -1.63% |
| 2026-04-01 | Dr. Nataliya AgafonovaChief Medical Officer | -13.15k | 14.72k | Sale to Issuer | 1.12 | 203.42k | -6.07% |
| 2026-04-01 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -13.15k | 14.72k | Sale to Issuer | 1.12 | 215.69k | -5.74% |
| 2026-04-01 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -8.63k | 9.67k | Sale to Issuer | 1.12 | 191.54k | -4.31% |
| 2026-04-01 | Mr. Stephen H. WillardCEO | -4.74k | 5.31k | Sale to Issuer | 1.12 | 289.73k | -1.61% |
| 2026-03-02 | Mr. Stephen H. WillardCEO | -105.53k | 57.52k | Sale to Issuer | 0.55 | 294.47k | -26.38% |
| 2026-01-02 | Mr. Than Powellインサイダー | -2.46k | 1.46k | Sale to Issuer | 0.59 | 125.59k | -1.92% |
| 2026-01-02 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -10.25k | 6.08k | Sale to Issuer | 0.59 | 228.83k | -4.29% |
| 2026-01-02 | Mr. Paul T. LehrGeneral Counsel & Secretary | -6.95k | 4.12k | Sale to Issuer | 0.59 | 344.18k | -1.98% |
| 2026-01-02 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -10.70k | 6.35k | Sale to Issuer | 0.59 | 200.18k | -5.07% |
| 2026-01-02 | Dr. Nataliya AgafonovaChief Medical Officer | -10.25k | 6.08k | Sale to Issuer | 0.59 | 216.56k | -4.52% |
| 2025-10-01 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -7.61k | 5.65k | Sale to Issuer | 0.74 | 210.88k | -3.48% |
| 2025-10-01 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -11.88k | 8.82k | Sale to Issuer | 0.74 | 239.08k | -4.73% |
| 2025-10-01 | Mr. Paul T. LehrGeneral Counsel & Secretary | -4.94k | 3.67k | Sale to Issuer | 0.74 | 351.13k | -1.39% |
| 2025-10-01 | Mr. Than Powellインサイダー | -2.39k | 1.77k | Sale to Issuer | 0.74 | 128.06k | -1.83% |
| 2025-10-01 | Dr. Nataliya AgafonovaChief Medical Officer | -11.88k | 8.82k | Sale to Issuer | 0.74 | 226.81k | -4.98% |
| 2025-08-11 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | 11.77k | 0.00 | 買い | - | 250.96k | 4.92% |
| 2025-08-11 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | 29.42k | 0.00 | Open Market Derivative Acquisition | 0.85 | 29.42k | - |
| 2025-08-11 | Mr. Khoso Baluchインサイダー | 11.77k | 0.00 | 買い | - | 52.52k | 28.87% |
| 2025-08-11 | Mr. Khoso Baluchインサイダー | 29.42k | 0.00 | Open Market Derivative Acquisition | 0.85 | 29.42k | - |
| 2025-07-01 | Dr. Nataliya AgafonovaChief Medical Officer | -7.43k | 9.51k | Sale to Issuer | 1.28 | 136.70k | -5.16% |
| 2025-07-01 | Mr. Devin BlassCTO and Senior VP of Chemistry, Manufacturing & Controls | -4.60k | 5.89k | Sale to Issuer | 1.28 | 116.49k | -3.80% |
| 2025-07-01 | Ms. Lisa A. LocklearCFO, Exec. VP & Treasurer | -7.43k | 9.51k | Sale to Issuer | 1.28 | 137.20k | -5.14% |
| 2025-07-01 | Mr. Paul T. LehrGeneral Counsel & Secretary | -1.56k | 2.00k | Sale to Issuer | 1.28 | 254.07k | -0.61% |
| 2025-07-01 | Mr. Mohamed Wa'el Ahmed Hashadインサイダー | -13.15k | 16.83k | Sale to Issuer | 1.28 | 240.90k | -5.17% |
| 2025-06-23 | Mr. Paul T. LehrGeneral Counsel & Secretary | -64.16k | 73.78k | Sale to Issuer | 1.15 | 255.64k | -20.06% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。